相关实验视频

Updated: Jul 17, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.7K

在乳腺癌中确定Ki-67的最佳切断点:单中心体验

Wang Li1,2, Ning Lu3, Caiping Chen2

  • 1School of Graduate, Bengbu Medical College, Bengbu, China.

The Journal of international medical research
|August 31, 2023
PubMed
概括

乳腺癌扩散的标志物Ki-67的最佳切割值为30%. 这一发现有助于预测雌激素受体阳性和人体表皮生长因子受体2-阴性乳腺癌患者的预后和瘤恶性.

关键词:
在 Ki-67 机器人 机器人乳腺癌 乳腺癌 乳腺癌这是一个切断点.恶性瘤是一种恶性瘤.分子亚型 分子亚型预后 预后 预后

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice09:17

A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice

Published on: January 5, 2021

7.4K

相关概念视频

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178